tranexamic acid has been researched along with Chronic Kidney Diseases in 3 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The PBM protocol consisted of epoetin (EPO) alfa therapy prescribed by the surgeon, routine administration of tranexamic acid (TXA), an avascular approach to the hip and postoperative prophylaxis of thromboembolism." | 4.02 | Application of an adjusted patient blood management protocol in patients undergoing elective total hip arthroplasty: towards a zero-percent transfusion rate in renal patients-results from an observational cohort study. ( Fennema, P; Hourlier, H, 2021) |
| "Tranexamic acid (TXA) is a common antifibrinolytic agent used to minimize bleeding in cardiac surgery." | 1.48 | Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen. ( Beattie, WS; Bojko, B; Jerath, A; Looby, N; Pang, KS; Pawliszyn, J; Reyes-Garces, N; Vasiljevic, T; Wąsowicz, M; Wijeysundera, D; Yang, QJ; Yau, TM, 2018) |
| "She had no further episodes of convulsion till dis-charge and during the two months of follow-up." | 1.40 | Tranexamic acid overdosage-induced generalized seizure in renal failure. ( Agarwal, SK; Bhat, A; Bhowmik, DM; Dogra, M; Vibha, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hourlier, H | 1 |
| Fennema, P | 1 |
| Jerath, A | 1 |
| Yang, QJ | 1 |
| Pang, KS | 1 |
| Looby, N | 1 |
| Reyes-Garces, N | 1 |
| Vasiljevic, T | 1 |
| Bojko, B | 1 |
| Pawliszyn, J | 1 |
| Wijeysundera, D | 1 |
| Beattie, WS | 1 |
| Yau, TM | 1 |
| Wąsowicz, M | 1 |
| Bhat, A | 1 |
| Bhowmik, DM | 1 |
| Vibha, D | 1 |
| Dogra, M | 1 |
| Agarwal, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass[NCT01609686] | 49 participants (Actual) | Observational | 2012-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for tranexamic acid and Chronic Kidney Diseases
| Article | Year |
|---|---|
Application of an adjusted patient blood management protocol in patients undergoing elective total hip arthroplasty: towards a zero-percent transfusion rate in renal patients-results from an observational cohort study.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic | 2021 |
Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen.
Topics: Aged; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Drug Administrat | 2018 |
Tranexamic acid overdosage-induced generalized seizure in renal failure.
Topics: Anticonvulsants; Antifibrinolytic Agents; Drug Overdose; Female; Humans; Kidney; Menorrhagia; Middle | 2014 |